Experience

Davis Polk advised Banco de Crédito del Perú in connection with an offering of $850 million aggregate principal amount of 3.125% subordinated fixed-to-fixed-rate notes due 2030 (callable…

Davis Polk advised the sole book-running manager in connection with the $215.6 million common stock offering of 6,900,000 shares of common stock of Editas Medicine, Inc. The common…

Davis Polk advised the representative of the initial purchasers of a Rule 144A/Regulation S offering by Acadia Healthcare Company, Inc. of $450 million aggregate principal amount of its 5…

Davis Polk advised the representative of the initial purchasers in connection with a Rule 144A/Regulation S offering by Viasat, Inc. of $400 million aggregate principal amount of its 6.500%…

Davis Polk advised the initial purchaser in connection with a Rule 144A offering by CryoLife, Inc. of $100 million aggregate principal amount of its 4.250% convertible senior notes due 2025…

Davis Polk advised the underwriters in connection with a public offering of 6,666,667 shares of common stock of IDEAYA Biosciences, Inc. at $15.00 per share, for total gross proceeds of …

Davis Polk advised the lead manager, sole book-runner and representative of the several underwriters in connection with an SEC-registered offering by Bank of America Corporation of $6…

Davis Polk advised the joint bookrunners on the equity offering of common shares of Via Varejo S.A. for an aggregate amount of approximately R$4.5 billion (approximately $860 million). The…

Davis Polk advised Credicorp Ltd. in connection with its $500 million offering of 2.750% notes due 2025, which were issued pursuant to Rule 144A and Regulation S under the Securities Act…

Davis Polk advised the dealer manager in connection with an SEC-registered rights offering by Liberty Media Corporation. A total of 29,594,089 new shares were subscribed for in the rights…